eXmoor pharma is a full service Cell & Gene Therapy CDMO with over 20 years of manufacturing experience, serving 150+ clients. The company offers expert solutions at all stages of the development journey, from early process development and scale-up to GMP manufacture, fill and finish, and QP release. Their transparent and collaborative approach aims to de-risk and streamline projects, maximizing the chances of product success.
Founded in 2004 and headquartered in the United Kingdom, eXmoor pharma operates in the Biotechnology and Life Sciences industries.
Notably, the company secured a $35.00M Series A investment on 30 May 2023, with backing from Kineticos Ventures and MVM Life Science Partners.